GLP-1 Reduces Psychiatric Hospitalization and Sick Leave by 42%

A 10-year longitudinal study of approximately 100,000 patients showed semaglutide reduced psychiatric hospitalizations and sick leave by 42%, depression risk by 44%, and anxiety by 38%.